Colorectal Cancer Pipeline Review, 2015
Summary
GlobalData's Medical Devices sector report, Colorectal Cancer Pipeline Review, 2015 provides an overview of Colorectal Cancer diagnostic tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer diagnostic tests pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Colorectal Cancer diagnostic tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Colorectal Cancer diagnostic tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to
Formulate significant competitor information, analysis, and insights to improve R & D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Colorectal Cancer diagnostic tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the products current stage of development, territory and estimated launch date
Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 16
2 Introduction 17
2.1 Colorectal Cancer Overview 17
3 Products under Development 18
3.1 Colorectal Cancer - Pipeline Products by Stage of Development 18
3.2 Colorectal Cancer - Pipeline Products by Territory 19
3.3 Colorectal Cancer - Pipeline Products by Regulatory Path 20
3.4 Colorectal Cancer - Pipeline Products by Estimated Approval Date 21
3.5 Colorectal Cancer - Ongoing Clinical Trials 22
4 Colorectal Cancer - Pipeline Products under Development by Companies 23
4.1 Colorectal Cancer Companies - Pipeline Products by Stage of Development 23
4.2 Colorectal Cancer - Pipeline Products by Stage of Development 28
5 Colorectal Cancer Companies and Product Overview 33
5.1 A2K Technologies Company Overview 33
5.2 Abbott Diagnostics Company Overview 34
5.3 Advanced Marker Discovery, S.L. Company Overview 40
5.4 Advpharma Inc. Company Overview 41
5.5 Ambergen, Inc. Company Overview 42
5.6 Ambrilia Biopharma Inc. Company Overview 44
5.7 Applied Proteomics, Inc. Company Overview 45
5.8 Arizona State University Company Overview 46
5.9 ArtemixRx Company Overview 47
5.10 Asuragen, Inc. Company Overview 48
5.11 Bio Mark Ltd Company Overview 49
5.12 Biocartis SA Company Overview 50
5.13 Biodesix Inc. Company Overview 51
5.14 BioMarCare Technologies Ltd. Company Overview 52
5.15 BioMark Diagnostics Inc. Company Overview 54
5.16 BioMark Technologies Inc. Company Overview 55
5.17 BioMarker Strategies, LLC Company Overview 56
5.18 bioMerieux S.A. Company Overview 57
5.19 Biomoda, Inc. (Inactive) Company Overview 59
5.20 Biosceptre (Aust) Pty Ltd Company Overview 60
5.21 BioSystems International Company Overview 61
5.22 Biotechnostics GmbH Company Overview 62
5.23 Biotron Limited Company Overview 63
5.24 Castle Biosciences Incorporated Company Overview 65
5.25 Cellmid Limited Company Overview 66
5.26 Ceres Nanosciences, Inc. Company Overview 69
5.27 Cernostics Inc. Company Overview 70
5.28 ChemImage Corporation Company Overview 71
5.29 China Sky One Medical, Inc. Company Overview 73
5.30 Chinese University of Hong Kong Company Overview 74
5.31 Chronix Biomedical, Inc. Company Overview 76
5.32 Cleveland Diagnostics Inc. Company Overview 77
5.33 ColoPrev Company Overview 78
5.34 Columbia University Company Overview 79
5.35 Courtagen Life Sciences, Inc. Company Overview 80
5.36 CS-Keys, Inc. Company Overview 81
5.37 Dartmouth College Company Overview 82
5.38 Di.V.A.L Toscana srl Company Overview 84
5.39 diaDexus, Inc. Company Overview 85
5.40 DiagnoCure Inc. Company Overview 89
5.41 Diaxonhit S.A. Company Overview 92
5.42 EDP Biotech Corporation Company Overview 94
5.43 Epigenomics AG Company Overview 95
5.44 Eureka Genomics Corporation Company Overview 99
5.45 Eventus Diagnostics, Inc. Company Overview 100
5.46 Exact Sciences Corporation Company Overview 101
5.47 Exiqon A/S Company Overview 105
5.48 Exosomics Siena SpA Company Overview 108
5.49 Fina Biotech Company Overview 109
5.50 GenomicTree, Inc. Company Overview 110
5.51 Ghent University Company Overview 112
5.52 GlycoZym Company Overview 113
5.53 Health Discovery Corporation Company Overview 114
5.54 Human Metabolome Technologies, Inc. Company Overview 115
5.55 Ikonisys, Inc. Company Overview 116
5.56 Innovative Health Diagnostics Company Overview 117
5.57 IntegraGen SA Company Overview 119
5.58 InterGenetics Incorporated Company Overview 121
5.59 IV Diagnostics, Inc. Company Overview 122
5.60 Lab21 Limited Company Overview 123
5.61 Laboratorios Alpha San Ignacio Pharma S.L. Company Overview 124
5.62 LX Diagnostics Company Overview 125
5.63 MabCure Inc. Company Overview 126
5.64 Matrix-Bio, Inc. Company Overview 127
5.65 Mayo Clinic Company Overview 130
5.66 MDxHealth SA Company Overview 131
5.67 Metabiomics Corporation Company Overview 134
5.68 Metabolomic Technologies Inc. Company Overview 135
5.69 Metabolon, Inc. Company Overview 137
5.70 MetaStat, Inc. Company Overview 138
5.71 Milagen, Inc. Company Overview 140
5.72 Miraculins Inc. Company Overview 141
5.73 Mode Dx Ltd. Company Overview 143
5.74 Myriad Genetics, Inc. Company Overview 144
5.75 Nanosphere, Inc. Company Overview 146
5.76 Neogenix Oncology, Inc. Company Overview 148
5.77 NetScientific Plc Company Overview 151
5.78 Norda ASA Company Overview 152
5.79 Novel Bio-spectrum Technologies, Inc. Company Overview 154
5.80 Nuclea Biotechnologies Inc. Company Overview 155
5.81 Nuvera Biosciences, Inc. Company Overview 156
5.82 OncoVista Innovative Therapies, Inc. Company Overview 157
5.83 On-Q-ity, Inc. (Inactive) Company Overview 159
5.84 Origin Sciences Limited Company Overview 160
5.85 Orion Genomics LLC Company Overview 161
5.86 OTraces Inc. Company Overview 163
5.87 Oxford Cancer Biomarkers Company Overview 164
5.88 Oxford Gene Technology Limited Company Overview 165
5.89 Pacific Edge Limited Company Overview 166
5.90 Panacea Pharmaceuticals, Inc. Company Overview 167
5.91 PleX Diagnostics Company Overview 168
5.92 Prediction Sciences Company Overview 169
5.93 Protagen AG Company Overview 170
5.94 Rosetta Genomics, Ltd. Company Overview 171
5.95 Scienion AG Company Overview 172
5.96 Seegene, Inc. Company Overview 173
5.97 Shuwen Biotech Co. Ltd. Company Overview 175
5.98 Siamab Therapeutics, Inc. Company Overview 176
5.99 Sienna Cancer Diagnostics Ltd Company Overview 177
5.100 Skuldtech France Company Overview 178
5.101 Sysmex Corporation Company Overview 179
5.102 Tel Aviv University Company Overview 181
5.103 Texas A&M University Company Overview 182
5.104 The Johns Hopkins University Company Overview 183
5.105 TheraDiag SA Company Overview 185
5.106 Todos Medical Company Overview 189
5.107 Universite De Lyon Company Overview 190
5.108 University of Alabama at Birmingham Company Overview 191
5.109 University of Chicago Company Overview 194
5.110 University of Texas at Austin Company Overview 195
5.111 US Biomarkers, Inc. Company Overview 196
5.112 Vanderbilt University Company Overview 197
5.113 Vermillion, Inc. Company Overview 201
5.114 Viomics Inc. Company Overview 203
5.115 Vitatex Inc. Company Overview 204
5.116 VolitionRX Ltd. Company Overview 206
5.117 XEPTAGEN SpA Company Overview 210
6 Colorectal Cancer- Recent Developments 212
7 Appendix 253
7.1 Methodology 253
7.2 About GlobalData 255
7.3 Contact Us 256
7.4 Disclaimer 256
List Of Tables
1.1 List of Tables
Table 1: Colorectal Cancer - Pipeline Products by Stage of Development 20
Table 2: Colorectal Cancer - Pipeline Products by Territory 21
Table 3: Colorectal Cancer - Pipeline Products by Regulatory Path 22
Table 4: Colorectal Cancer - Pipeline Products by Estimated Approval Date 23
Table 5: Colorectal Cancer - Ongoing Clinical Trials 24
Table 6: Colorectal Cancer Companies - Pipeline Products by Stage of Development 25
Table 7: Colorectal Cancer - Pipeline Products by Stage of Development 30
Table 8: A2K Technologies Pipeline Products & Ongoing Clinical Trials Overview 35
Table 9: Colospec - Product Status 35
Table 10: Colospec - Product Description 35
Table 11: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 36
Table 12: AKT Companion Diagnostic Assay - Colorectal Cancer - Product Status 37
Table 13: AKT Companion Diagnostic Assay - Colorectal Cancer - Product Description 37
Table 14: cMET Companion Diagnostic Assay - Colorectal Cancer - Product Status 38
Table 15: cMET Companion Diagnostic Assay - Colorectal Cancer - Product Description 38
Table 16: PIK3CA Companion Diagnostic Assay - Colorectal Cancer - Product Status 39
Table 17: PIK3CA Companion Diagnostic Assay - Colorectal Cancer - Product Description 39
Table 18: PTEN Companion Diagnostic Assay - Colorectal Cancer - Product Status 40
Table 19: PTEN Companion Diagnostic Assay - Colorectal Cancer - Product Description 40
Table 20: RealTime mS9 Colorectal Cancer Test - Product Status 41
Table 21: RealTime mS9 Colorectal Cancer Test - Product Description 41
Table 22: Advanced Marker Discovery, S.L. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 23: Screening Test - Colon Cancer - Product Status 42
Table 24: Screening Test - Colon Cancer - Product Description 42
Table 25: Advpharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 26: Molecular Diagnostic Biomarker - Colorectal Cancer - Product Status 43
Table 27: Molecular Diagnostic Biomarker - Colorectal Cancer - Product Description 43
Table 28: Ambergen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
Table 29: Veracode - Colorectal Cancer - Product Status 45
Table 30: Veracode - Colorectal Cancer - Product Description 45
Table 31: Ambrilia Biopharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 32: Colopath/ColorectAlert - Product Status 46
Table 33: Colopath/ColorectAlert - Product Description 46
Table 34: Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 35: API Diagnostic Test - Colorectal Cancer - Product Status 47
Table 36: API Diagnostic Test - Colorectal Cancer - Product Description 47
Table 37: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 48
Table 38: Biomarker Test - Colorectal Cancer - Product Status 48
Table 39: Biomarker Test - Colorectal Cancer - Product Description 48
Table 40: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 49
Table 41: ArtemixRx Prognostic Test - Colon Cancer - Product Status 49
Table 42: ArtemixRx Prognostic Test - Colon Cancer - Product Description 49
Table 43: Asuragen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 44: Molecular Diagnostic Assay - Colon Cancer - Product Status 50
Table 45: Molecular Diagnostic Assay - Colon Cancer - Product Description 50
Table 46: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
Table 47: Diagnostic Test - Colorectal Adenoma - Product Status 51
Table 48: Diagnostic Test - Colorectal Adenoma - Product Description 51
Table 49: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 52
Table 50: MSI-Biomarker Diagnostic Test - Colorectal Cancer - Product Status 52
Table 51: MSI-Biomarker Diagnostic Test - Colorectal Cancer - Product Description 52
Table 52: Biodesix Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
Table 53: VeriStrat - Colorectal Cancer - Product Status 53
Table 54: VeriStrat - Colorectal Cancer - Product Description 53
Table 55: BioMarCare Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 54
Table 56: Colon MarCarePlex - Product Status 54
Table 57: Colon MarCarePlex - Product Description 54
Table 58: mCRC-Strat - Product Status 55
Table 59: mCRC-Strat - Product Description 55
Table 60: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
Table 61: Metabolomics-based Diagnostic Assay - Colon Cancer - Product Status 56
Table 62: Metabolomics-based Diagnostic Assay - Colon Cancer - Product Description 56
Table 63: BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
Table 64: Biomarker Assay - Colorectal Cancer - Product Status 57
Table 65: Biomarker Assay - Colorectal Cancer - Product Description 57
Table 66: BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
Table 67: Ex Vivo Biomarker Test - Colon Cancer - Product Status 58
Table 68: Ex Vivo Biomarker Test - Colon Cancer - Product Description 58
Table 69: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 59
Table 70: Diagnostic Test - Colorectal Cancer - Product Status 60
Table 71: Diagnostic Test - Colorectal Cancer - Product Description 60
Table 72: Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 61
Table 73: CyPath Diagnostic Assay - Colorectal Cancer - Product Status 61
Table 74: CyPath Diagnostic Assay - Colorectal Cancer - Product Description 61
Table 75: Biosceptre (Aust) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
Table 76: Colorectal Cancer IHC Diagnostic Test - Product Status 62
Table 77: Colorectal Cancer IHC Diagnostic Test - Product Description 62
Table 78: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 63
Table 79: Diagnostic Test - Colon Cancer - Product Status 63
Table 80: Diagnostic Test - Colon Cancer - Product Description 63
Table 81: Biotechnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 64
Table 82: Diagnostic Test - Colorectal Cancer - Product Status 64
Table 83: Diagnostic Test - Colorectal Cancer - Product Description 64
Table 84: Biotron Limited Pipeline Products & Ongoing Clinical Trials Overview 65
Table 85: C-Test - Colorectal Cancer - Product Status 66
Table 86: C-Test - Colorectal Cancer - Product Description 66
Table 87: Castle Biosciences Incorporated Pipeline Products & Ongoing Clinical Trials Overview 67
Table 88: DecisionDx- Rectal Cancer - Product Status 67
Table 89: DecisionDx- Rectal Cancer - Product Description 67
Table 90: Cellmid Limited Pipeline Products & Ongoing Clinical Trials Overview 68
Table 91: MK-ELISA Assay - Colorectal Cancer - Product Status 69
Table 92: MK-ELISA Assay - Colorectal Cancer - Product Description 69
Table 93: MK-ELISA Assay - Metastatic Colorectal Cancer - Product Status 70
Table 94: MK-ELISA Assay - Metastatic Colorectal Cancer - Product Description 70
Table 95: Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 96: Nanotrap Colon Cancer Biomarker Test - Product Status 71
Table 97: Nanotrap Colon Cancer Biomarker Test - Product Description 71
Table 98: Cernostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
Table 99: TissueCypher Colon Cancer Test - Product Status 72
Table 100: TissueCypher Colon Cancer Test - Product Description 72
Table 101: ChemImage Corporation Pipeline Products & Ongoing Clinical Trials Overview 73
Table 102: RACC Test - Colorectal Cancer - Product Status 74
Table 103: RACC Test - Colorectal Cancer - Product Description 74
Table 104: China Sky One Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 105: Diagnostic Kit - Rectum Cancer - Product Status 75
Table 106: Diagnostic Kit - Rectum Cancer - Product Description 75
Table 107: Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 76
Table 108: Biomarker Test - Colorectal Cancer - Product Status 76
Table 109: Biomarker Test - Colorectal Cancer - Product Description 76
Table 110: Micro-RNA Based Biomarker Assay - Colon Cancer - Product Status 77
Table 111: Micro-RNA Based Biomarker Assay - Colon Cancer - Product Description 77
Table 112: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
Table 113: Companion Diagnostic Test - Colorectal Cancer - Product Status 78
Table 114: Companion Diagnostic Test - Colorectal Cancer - Product Description 78
Table 115: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
Table 116: Blood-Based Diagnostic Test - Colon Cancer - Product Status 79
Table 117: Blood-Based Diagnostic Test - Colon Cancer - Product Description 79
Table 118: ColoPrev Pipeline Products & Ongoing Clinical Trials Overview 80
Table 119: Blood-Based Diagnostic Test - Colorectal Cancer - Product Status 80
Table 120: Blood-Based Diagnostic Test - Colorectal Cancer - Product Description 80
Table 121: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 81
Table 122: IGFBP-3 Diagnostic Test - Product Status 81
Table 123: IGFBP-3 Diagnostic Test - Product Description 81
Table 124: Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 125: Colorectal Cancer Diagnostic Panel - Product Status 82
Table 126: Colorectal Cancer Diagnostic Panel - Product Description 82
Table 127: CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83
List Of Figures
1.2 List of Figures
Figure 1: Colorectal Cancer - Pipeline Products by Stage of Development 20
Figure 2: Colorectal Cancer - Pipeline Products by Territory 21
Figure 3: Colorectal Cancer - Pipeline Products by Regulatory Path 22
Figure 4: Colorectal Cancer - Pipeline Products by Estimated Approval Date 23
Figure 5: Colorectal Cancer - Ongoing Clinical Trials 24
